Abstract
Asthma biomarkers from a variety of sources have variable clinical utility, performance characteristics, and applicability. Sputum mast cells (MC) have been identified in stable, asymptomatic asthmatics, as well as more severe asthmatics. [Foresi, JACI, 1997; Fajt, AAAAI, 2011] Little is known about the treatment response to steroids in sputum MCs from different subtypes of asthma.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
